The long-term goals of this proposal center on the dissection of the biochemical pathways of sphingolipid metabolism and their role in cell regulation with particular emphasis on """"""""sphingomyelin turnover"""""""" and its role in cell differentiation and proliferation. The hypothesis that ceramide functions as a second messenger, lipid mediator of cell differentiation, will be investigated. Control and modulation of cellular responses by extracellular agents involves a number of signal transduction mechanisms. Recent work from this laboratory has resulted in the discovery of a novel mechanism of signal transduction involving the turnover of sphingomyelin, an important cell membrane sphingolipid. This """"""""sphingomyelin cycle"""""""" appears to operate in response to certain inducers of cell differentiation (including tumor necrosis factor alpha, gamma-interferon, vitamin D(3) and other steroids and anti-steroids) and it appears to be an important mechanism mediating their effects on cell proliferation/differentiation.
The specific aims of this proposal are, therefore, directed at; 1) defining """"""""sphingomyelin turnover"""""""" in a number of cell systems and identifying inducers of sphingomyelin hydrolysis; 2) determining the metabolic pathways involved in sphingomyelin turnover with particular attention aimed at purifying and characterizing the regulation of a novel neutral sphingomyelinase; and 3) determining the physiologic role of sphingomyelin turnover and ceramide generation in cell regulation. These studies will establish a role for sphingomyelin hydrolysis in different cellular responses. More importantly, the central hypothesis that the breakdown product of sphingomyelin hydrolysis, i.e., ceramide, functions as a second messenger will be evaluated by; a) measuring ceramide levels in response to inducers of differentiation; b) using cell permeable ceramide analogs as exogenous agents to probe the function of sphingomyelin hydrolysis and ceramide generation; and c) defining the mechanism of action of ceramide with its possible relationship to protein kinase C regulation. These studies are beginning to define a novel area of signal transduction and cell regulation at the biochemical and molecular level with particular attention to its relevance to cell differentiation and regulation of proliferation. This improved understanding may have significant impact in the areas of cancer biology and cell regulation.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM043825-03
Application #
3302902
Study Section
Physiological Chemistry Study Section (PC)
Project Start
1991-01-01
Project End
1994-12-31
Budget Start
1993-01-01
Budget End
1993-12-31
Support Year
3
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Duke University
Department
Type
Schools of Medicine
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Lu, Zhongyang; Li, Yanchun; Jin, Junfei et al. (2015) GPR40/FFA1 and neutral sphingomyelinase are involved in palmitate-boosted inflammatory response of microvascular endothelial cells to LPS. Atherosclerosis 240:163-73
Rajagopalan, Vinodh; Canals, Daniel; Luberto, Chiara et al. (2015) Critical determinants of mitochondria-associated neutral sphingomyelinase (MA-nSMase) for mitochondrial localization. Biochim Biophys Acta 1850:628-39
Shamseddine, A A; Clarke, C J; Carroll, B et al. (2015) P53-dependent upregulation of neutral sphingomyelinase-2: role in doxorubicin-induced growth arrest. Cell Death Dis 6:e1947
Spincemaille, Pieter; Matmati, Nabil; Hannun, Yusuf A et al. (2014) Sphingolipids and mitochondrial function in budding yeast. Biochim Biophys Acta 1840:3131-7
Matmati, Nabil; Metelli, Alessandra; Tripathi, Kaushlendra et al. (2013) Identification of C18:1-phytoceramide as the candidate lipid mediator for hydroxyurea resistance in yeast. J Biol Chem 288:17272-84
Khavandgar, Zohreh; Poirier, Christophe; Clarke, Christopher J et al. (2011) A cell-autonomous requirement for neutral sphingomyelinase 2 in bone mineralization. J Cell Biol 194:277-89
Clarke, Christopher J; Cloessner, Emily A; Roddy, Patrick L et al. (2011) Neutral sphingomyelinase 2 (nSMase2) is the primary neutral sphingomyelinase isoform activated by tumour necrosis factor-? in MCF-7 cells. Biochem J 435:381-90
Barbosa, Antonio Daniel; Osorio, Hugo; Sims, Kellie J et al. (2011) Role for Sit4p-dependent mitochondrial dysfunction in mediating the shortened chronological lifespan and oxidative stress sensitivity of Isc1p-deficient cells. Mol Microbiol 81:515-27
Wu, Bill X; Clarke, Christopher J; Matmati, Nabil et al. (2011) Identification of novel anionic phospholipid binding domains in neutral sphingomyelinase 2 with selective binding preference. J Biol Chem 286:22362-71
Hernandez-Corbacho, Maria Jose; Jenkins, Russell W; Clarke, Christopher J et al. (2011) Accumulation of long-chain glycosphingolipids during aging is prevented by caloric restriction. PLoS One 6:e20411

Showing the most recent 10 out of 27 publications